Data_Sheet_3_Elevated Serum Tenascin-C Predicts Mortality in Critically Ill Patients With Multiple Organ Dysfunction.PDF
Background: Multiple organ dysfunction is a complex and lethal clinical feature with heterogeneous causes and is usually characterized by tissue injury of multiple organs. Tenascin-C (TNC) is a matricellular protein that is rarely expressed in most of the adult tissues, but re-induced following injury. This study aimed to evaluate serum TNC in predicting mortality in critically ill patients with multiple organ dysfunction.
Methods: Adult critically ill patients with at least two organs dysfunction and an increase of Sequential Organ Failure Assess (SOFA) score ≥ 2 points within 7 days were prospectively enrolled into two independent cohorts. The emergency (derivation) cohort was a consecutive series and the patients were from Emergency Department. The inpatient (validation) cohort was a convenience series and the patients were from medical wards. Their serum samples at the first 24 h after enrollment were collected and subjected to TNC measurement using ELISA. The association between serum TNC level and 28-day all-cause mortality was investigated, and then the predictive value of serum TNC was analyzed.
Results: A total of 110 patients with a median age of 64 years (53, 73) were enrolled in the emergency cohort. Compared to the survivors, serum TNC in the non-survivors was significantly higher (467.7 vs. 197.5 ng/ml, p < 0.001). Multivariate logistic regression analysis revealed that the association between serum TNC and 28-day mortality was independent of sepsis or critical illness scores such as SOFA, Acute Physiology and Chronic Health Evaluation (APACHE II), and Simplified Acute Physiology Score (SAPS II), respectively (p < 0.001 for each). The area under receiver operating characteristic curve of serum TNC for predicting mortality was 0.803 (0.717–0.888) (p < 0.001), similar with SOFA 0.808 (0.725–0.891), APACHE II 0.762 (0.667–0.857), and SAPS II 0.779 (0.685–0.872). The optimal cut-off value of serum TNC was 298.2 ng/ml. Kaplan–Meier analysis showed that the survival of patients with serum TNC ≥ 300 ng/ml was significantly worse than that of patients with serum TNC < 300 ng/ml. This result was validated in the inpatient cohort. The sensitivity and specificity of serum TNC ≥ 300 ng/ml for predicting mortality were 74.3 and 74.7% in the emergency cohort, and 63.0 and 70.1% in the inpatient cohort, respectively.
Conclusion: Serum TNC was associated with mortality in critically ill patients with multiple organ dysfunction, and would be used as a prognostic tool for predicting mortality in this population.
History
References
- https://doi.org//10.1378/chest.109.4.1033
- https://doi.org//10.1111/j.1399-6576.2008.01586.x
- https://doi.org//10.1097/00003246-199811000-00016
- https://doi.org//10.1001/jama.2016.20328
- https://doi.org//10.1111/jocs.14331
- https://doi.org//10.1177/0885066619882675
- https://doi.org//10.1097/SHK.0000000000001481
- https://doi.org//10.1007/s00018-011-0783-6
- https://doi.org//10.1371/journal.pone.0062076
- https://doi.org//10.1016/j.humpath.2008.12.017
- https://doi.org//10.1002/path.1730
- https://doi.org//10.1002/(SICI)1096-9896(199607)179%3A3<321%3A%3AAID-PATH555>3.0.CO;2-8
- https://doi.org//10.1002/ejhf.464
- https://doi.org//10.1002/path.2099
- https://doi.org//10.1152/ajplung.00385.2009
- https://doi.org//10.1186/1471-2466-14-120
- https://doi.org//10.1006/exmp.2002.2432
- https://doi.org//10.1681/ASN.2016020165
- https://doi.org//10.1016/j.ijcard.2013.04.211
- https://doi.org//10.1152/ajpcell.00353.2020
- https://doi.org//10.1001/jama.2016.0287
- https://doi.org//10.1097/00003246-198510000-00009
- https://doi.org//10.1001/jama.270.24.2957
- https://doi.org//10.1111/aas.13527
- https://doi.org//10.1038/s41581-018-0005-7
- https://doi.org//10.3390/ijms18102200
- https://doi.org//10.1007/s10753-018-0739-1
- https://doi.org//10.1016/j.carpath.2018.10.005
- https://doi.org//10.1002/jor.20366
- https://doi.org//10.1016/j.bbamcr.2008.12.012
- https://doi.org//10.1186/ar4105
- https://doi.org//10.3899/jrheum.141365
- https://doi.org//10.1007/s10067-017-3938-5
- https://doi.org//10.1186/s13075-015-0862-4
- https://doi.org//10.1016/j.lfs.2015.09.011
- https://doi.org//10.1016/j.jacc.2006.03.033
- https://doi.org//10.1016/j.hlc.2012.10.005
- https://doi.org//10.1536/ihj.18-462
- https://doi.org//10.5551/jat.6577
- https://doi.org//10.1016/j.cardfail.2012.02.009
- https://doi.org//10.1186/s12871-018-0634-1
- https://doi.org//10.1016/j.ijcard.2015.05.009
Usage metrics
Read the peer-reviewed publication
Categories
- Radiology and Organ Imaging
- Foetal Development and Medicine
- Obstetrics and Gynaecology
- Primary Health Care
- Medical and Health Sciences not elsewhere classified
- Dermatology
- Emergency Medicine
- Gastroenterology and Hepatology
- Geriatrics and Gerontology
- Intensive Care
- Medical Genetics (excl. Cancer Genetics)
- Nephrology and Urology
- Nuclear Medicine
- Orthopaedics
- Otorhinolaryngology
- Pathology (excl. Oral Pathology)
- Family Care